Thrombi Clinical Trials in Reims
2 recruitingReims, France
Showing 1–2 of 2 trials
Recruiting
Phase 3
Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass
Acquired Antithrombin Deficiency
Octapharma120 enrolled24 locationsNCT06096116
Recruiting
Phase 3
Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery
Congenital Antithrombin Deficiency
Octapharma38 enrolled30 locationsNCT04918173